MedPath

Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors

Not Applicable
Completed
Conditions
Stage I Rectosigmoid Cancer
Cancer Survivor
Stage II Rectosigmoid Cancer
Stage III Rectosigmoid Cancer
Interventions
Other: Informational Intervention
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Other: Survey Administration
Behavioral: Telephone-Based Intervention
Registration Number
NCT03063918
Lead Sponsor
City of Hope Medical Center
Brief Summary

This pilot clinical trial studies how well personalized dietary intervention works in managing bowel dysfunction and improving quality of life in stage I-III rectosigmoid cancer survivors. Personalized dietary intervention may help people understand bowel symptoms, identify helpful and troublesome foods for bowel symptoms, adjust diets and food preparation based on food triggers, and coach on healthy diet recommendations after cancer treatment.

Detailed Description

PRIMARY OBJECTIVES:

I. Administer and determine the feasibility of the personalized dietary intervention.

II. Using qualitative methods, evaluate the acceptability of the intervention as reported by survivors.

III. Explore decisional conflict associated with treatment decision-making in rectal cancer surgery.

OUTLINE:

At 6 months after standard of care treatment, patients receive 10 sessions of personalized dietary intervention over 30 minutes each over 4 months via the telephone. Patients also receive a workbook including reference materials and intervention content.

After completion of study, patients are followed up for 6 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Diagnosis of stage I-III cancers of the rectosigmoid colon or rectum
  • 6 months post-treatment completion
  • Have a permanent ostomy or anastomosis
  • English-speaking
  • All subjects must have the ability to understand and the willingness to sign a written informed consent
Exclusion Criteria
  • Patients with stage IV disease will be excluded from the study
  • Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Supportive Care (personalized dietary intervention)Informational InterventionAt 6 months after standard of care treatment, patients receive 10 sessions of personalized dietary intervention over 30 minutes each over 4 months via the telephone. Patients also receive a workbook including reference materials and intervention content.
Supportive Care (personalized dietary intervention)Survey AdministrationAt 6 months after standard of care treatment, patients receive 10 sessions of personalized dietary intervention over 30 minutes each over 4 months via the telephone. Patients also receive a workbook including reference materials and intervention content.
Supportive Care (personalized dietary intervention)Telephone-Based InterventionAt 6 months after standard of care treatment, patients receive 10 sessions of personalized dietary intervention over 30 minutes each over 4 months via the telephone. Patients also receive a workbook including reference materials and intervention content.
Supportive Care (personalized dietary intervention)Quality-of-Life AssessmentAt 6 months after standard of care treatment, patients receive 10 sessions of personalized dietary intervention over 30 minutes each over 4 months via the telephone. Patients also receive a workbook including reference materials and intervention content.
Supportive Care (personalized dietary intervention)Questionnaire AdministrationAt 6 months after standard of care treatment, patients receive 10 sessions of personalized dietary intervention over 30 minutes each over 4 months via the telephone. Patients also receive a workbook including reference materials and intervention content.
Primary Outcome Measures
NameTimeMethod
Acceptability assessed by semi-structured interviewUp to 6 months

Will be assessed through qualitative data analysis using conventional content analysis approach.

Quality of life assessed by City of Hope-Quality of Life-Colorectal CancerUp to 6 months

Descriptive statistics will be summarized using validated scoring procedures.

Bowel function assessed by Memorial Sloan Kettering Cancer Center Bowel Function ToolUp to 6 months

Descriptive statistics will be summarized using validated scoring procedures.

Feasibility assessed by patient enrollmentUp to 6 months

Will be assessed through: 1) the ratio of eligible participants to those enrolled and those who declines participation; 2) reasons for non-participation; 3) number of scheduled study encounters completed; 4) attrition rate between pre- and post-intervention; 5) reasons for attrition/dropout; 6) level of intervention participation including the total number of sessions, number of sessions completed without break-offs, number of break-offs, length (minutes) of sessions; and 7) the ratio of all participants to those who complete \>= 80% of the study.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

City of Hope Medical Center

🇺🇸

Duarte, California, United States

The University of Arizona Medical Center-University Campus

🇺🇸

Tucson, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath